CDK9-IN-31 (dimaleate)
CDK9-IN-31 dimaleate (Compound Z1) is a CDK9 inhibitor that inhibits cancer cell growth. CDK9-IN-31 dimaleate has the potential to be developed as an anticancer agent[1].
Product Specifications
UNSPSC
12352005
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cdk9-in-31-dimaleate.html
Solubility
10 mM in DMSO
Smiles
O=C(O)/C=C\C(O)=O.OC[C@@H](C)N[C@@H](CC1)CC[C@H]1NC2=CC(C3=CSC(NCC4(CCOCC4)C#N)=N3)=C(Cl)C=N2.O=C(O)/C=C\C(O)=O
Molecular Formula
C32H41ClN6O10S
Molecular Weight
737.22
References & Citations
[1]Fusheng Zhou, et al. CDK9 inhibitor and preparation method and application thereof. Patent CN116496267A.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
bs-41417R-BF350 100 µL
SARS-CoV-2 N Polyclonal Antibody, AbBy Fluor™ 350 Conjugated
Ask
View Details MBS6298060-01 0.1 mL
FARSB, CT (FARSB, FARSLB, FRSB, Phenylalanine-tRNA ligase beta subunit, Phenylalanyl-tRNA synthetase beta subunit) (MaxLight 490)
Ask
View Details MBS6298060-02 5x 0.1 mL
FARSB, CT (FARSB, FARSLB, FRSB, Phenylalanine-tRNA ligase beta subunit, Phenylalanyl-tRNA synthetase beta subunit) (MaxLight 490)
Ask
View Details 